
Zydus Presents Geographic Subgroup Analysis of Saroglitazar Trial in Primary Biliary Cholangitis
Zydus Therapeutics Inc, a wholly owned subsidiary of Zydus Lifesciences Limited, has presented new findings

Zydus Therapeutics Inc, a wholly owned subsidiary of Zydus Lifesciences Limited, has presented new findings

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration

Zydus Lifesciences Limited (Zydus) has received final approval from the United States Food and Drug

Zydus Lifesciences Limited has received regulatory approval to begin a Phase III clinical trial of

Zydus Lifesciences Ltd and Sunshine Healthcare have entered into a strategic joint venture to establish

Zydus Lifesciences Limited today announced the successful completion of its tender offer for the acquisition

Amplitude Surgical (Amplitude), a wholly owned subsidiary of Zydus MedTech France SAS and part of

Zydus Lifesciences Ltd announced on Wednesday that it has received final approval from the US

Zydus Lifesciences, a leading player in the pharmaceutical industry, has announced a significant milestone in

Pankaj Patel, the Chairman of Zydus Lifesciences, has revealed the group’s intention to designate around